Gastric medicine may be effective against COVID-19, research claims

June 6, 2020  13:25

The low-cost drug that is used today to treat the symptoms of indigestion can be effective in controlling COVID-19 in patients with no need for hospitalization, Gut reported referring to a new study

Researchers report 10 COVID-19 patients who took high doses of famotidine.

The most 'popular' dose was 80 mg three times a day, for an average of 11 days. Patients reported that they tolerated the medicine well, and all of them noted their health improved and the COVID-19 symptoms became less disturbing.

As reported, doctors rated the severity of the five main signs of the disease - including cough, shortness of breath, fatigue, headache, and loss of taste and smell. Symptoms lasted from 2 to 26 days. The average treatment period was 11 days but ranged from 5 to 21 days.

According to scientists, the study of these cases showed that the drug is well tolerated by the body and improves the well-being of COVID-19 patients who do not need hospitalization.

However, the available data are not enough to claim that famotidine is truly effective against COVID-19: to confirm its effectiveness, it is necessary to conduct clinical studies involving more people.

Follow Medicine on Facebook and Twitter

  • Video
  • Event calendar
  • Archive
  • Most read
  • Find us on Facebook
  • Poll
How much are you ready to pay monthly for health insurance?
7-10% of salary
10 000 AMD and more
Up to 10 000 drams
Up to 5000 drams
I don’t want to pay for insurance